tiprankstipranks
Tyra Bioscience (TYRA)
NASDAQ:TYRA
US Market
Holding TYRA?
Track your performance easily

Tyra Bioscience (TYRA) Financial Statements

63 Followers

Tyra Bioscience Financial Overview

Tyra Bioscience's market cap is currently ―. The company's EPS TTM is $-1.606; its P/E ratio is ―; Tyra Bioscience is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.48. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -24.02M$ -18.70M$ -18.19M$ -25.63M$ -23.96M
EBITDA$ -23.89M$ -18.58M$ -18.07M$ -25.53M$ -23.88M
Net Income Common Stockholders$ -24.02M$ -18.70M$ -18.19M$ -20.07M$ -21.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 360.13M$ 373.80M$ 382.46M$ 203.47M$ 215.65M
Total Assets$ 380.59M$ 392.46M$ 404.74M$ 225.86M$ 238.36M
Total Debt$ 6.32M$ 6.40M$ 6.49M$ 6.50M$ 6.11M
Net Debt$ -353.81M$ -367.40M$ -375.98M$ -196.97M$ -209.54M
Total Liabilities$ 18.30M$ 16.42M$ 14.86M$ 21.59M$ 16.19M
Stockholders Equity$ 362.29M$ 376.04M$ 389.88M$ 204.26M$ 222.17M
Cash Flow-
Free Cash Flow$ -17.95M$ -10.73M$ -22.16M$ -14.13M$ -17.23M
Operating Cash Flow$ -17.90M$ -10.26M$ -22.03M$ -13.53M$ -17.14M
Investing Cash Flow$ 21.56M$ -144.99M$ 18.07M$ -144.44M$ -83.00K
Financing Cash Flow$ 743.00K$ 373.00K$ 200.31M$ 324.00K$ 467.00K
Currency in USD

Tyra Bioscience Earnings and Revenue History

Tyra Bioscience Debt to Assets

Tyra Bioscience Cash Flow

Tyra Bioscience Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis